Open AccessSTUDY OF ANTIMULLERIAN HORMONE (AMH) LEVEL VARIATION IN FEMALES IN ASSISTED REPRODUCTIVE TECHNOLOGY (ART) CENTRE
Author(s) -
Supeeti Gupta,
Vds Jamwal,
S.L. Bodhankar,
K Mohanlal
Publication year - 2020
Publication title -
international journal of medical and biomedical studies
Language(s) - English
Resource type - Journals
eISSN - 2589-8698
pISSN - 2589-868X
DOI - 10.32553/ijmbs.v4i9.1382
Subject(s) - ovarian reserve , assisted reproductive technology , infertility , medicine , controlled ovarian hyperstimulation , gynecology , anti müllerian hormone , pregnancy rate , pregnancy , reproductive technology , obstetrics , hormone , biology , genetics , lactation
Study of AMH levels of patients of ART Centre and its variations has clinical relevance in the field of assisted reproductive technology. Diminished ovarian reserve has become a major cause of infertility. Anti-Mullerian hormone (AMH) seems to be a promising candidate to assess ovarian reserve and predict the response to controlled ovarian hyperstimulation (COH). The study is a prospective, observational study carried in Department of Anatomy in collaboration with Assisted Reproductive Technology centre at a tertiary care teaching hospital. The study is carried out on eighty females who had reported to ART centre for treatment for the first time, because of involuntary childlessness with at least 1 year of unprotected intercourse without pregnancy. In our study, eighty females were divided into four groups depending upon their AMH levels. The number of oocytes collected from each female on the day of oocyte pickup was documented. Comparison with previous studies was done. Knowledge of AMH levels will help gynaecologist to counsel the infertility patient prior to initiation of the IVF cycle. It not only allows the quantification of ovarian reserve but also predict the eventual ovarian response to ovarian stimulation and the clinical pregnancy.
Keywords: AntiMullerian Hormone, Assisted Reproductive Technology, Ovarian Reserve